These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 17476595)

  • 61. Biomarker Panel for the Diagnosis of Pancreatic Ductal Adenocarcinoma.
    Kim H; Kang KN; Shin YS; Byun Y; Han Y; Kwon W; Kim CW; Jang JY
    Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32492943
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Carbohydrate Antigen 19-9, Carcinoembryonic Antigen, and Carbohydrate Antigen 72-4 in Gastric Cancer: Is the Old Band Still Playing?
    Kotzev AI; Draganov PV
    Gastrointest Tumors; 2018 Sep; 5(1-2):1-13. PubMed ID: 30574476
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Utility of serum tumor markers as an aid in the differential diagnosis of patients with clinical suspicion of cancer and in patients with cancer of unknown primary site.
    Molina R; Bosch X; Auge JM; Filella X; Escudero JM; Molina V; Solé M; López-Soto A
    Tumour Biol; 2012 Apr; 33(2):463-74. PubMed ID: 22161237
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The clinical significance of ascitic fluid CEA in advanced gastric cancer with ascites.
    Jung M; Jeung HC; Lee SS; Park JY; Hong S; Lee SH; Noh SH; Chung HC; Rha SY
    J Cancer Res Clin Oncol; 2010 Apr; 136(4):517-26. PubMed ID: 19774395
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clinical usefulness of circulating tumor markers.
    Filella X; Rodríguez-Garcia M; Fernández-Galán E
    Clin Chem Lab Med; 2023 Apr; 61(5):895-905. PubMed ID: 36394981
    [TBL] [Abstract][Full Text] [Related]  

  • 66. False-positive findings for tumor markers after curative gastrectomy for gastric cancer.
    Ohtsuka T; Sato S; Kitajima Y; Tanaka M; Nakafusa Y; Miyazaki K
    Dig Dis Sci; 2008 Jan; 53(1):73-9. PubMed ID: 17476595
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Different roles of tumor marker monitoring after curative resections of gastric and colorectal cancers.
    Ohtsuka T; Nakafusa Y; Sato S; Kitajima Y; Tanaka M; Miyazaki K
    Dig Dis Sci; 2008 Jun; 53(6):1537-43. PubMed ID: 17932750
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The role of gastric distention in differentiating recurrent tumor from physiologic uptake in the remnant stomach on 18F-FDG PET.
    Yun M; Choi HS; Yoo E; Bong JK; Ryu YH; Lee JD
    J Nucl Med; 2005 Jun; 46(6):953-7. PubMed ID: 15937305
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Prognostic value of early postoperative tumor marker response in gastric cancer.
    Nam DH; Lee YK; Park JC; Lee H; Shin SK; Lee SK; Lee YC; Cheong JH; Hyung WJ; Noh SH; Kim CB
    Ann Surg Oncol; 2013 Nov; 20(12):3905-11. PubMed ID: 23807661
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Follow-up after curative resection for gastric cancer: Is it time to tailor it?
    Aurello P; Petrucciani N; Antolino L; Giulitti D; D'Angelo F; Ramacciato G
    World J Gastroenterol; 2017 May; 23(19):3379-3387. PubMed ID: 28596674
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Combined epithelial-mesenchymal transition with cancer stem cell-like marker as predictors of recurrence after radical resection for gastric cancer.
    Xu GF; Zhang WJ; Sun Q; Xu X; Zou X; Guan W
    World J Surg Oncol; 2014 Dec; 12():368. PubMed ID: 25441488
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prediction of recurrence after radical surgery for gastric cancer: a scoring system obtained from a prospective multicenter study.
    Marrelli D; De Stefano A; de Manzoni G; Morgagni P; Di Leo A; Roviello F
    Ann Surg; 2005 Feb; 241(2):247-55. PubMed ID: 15650634
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Patterns of initial recurrence in completely resected gastric adenocarcinoma.
    D'Angelica M; Gonen M; Brennan MF; Turnbull AD; Bains M; Karpeh MS
    Ann Surg; 2004 Nov; 240(5):808-16. PubMed ID: 15492562
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The use of tumor markers as predictors of prognosis in gastric cancer.
    Mihmanli M; Dilege E; Demir U; Coskun H; Eroglu T; Uysalol MD
    Hepatogastroenterology; 2004; 51(59):1544-7. PubMed ID: 15362797
    [TBL] [Abstract][Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.